Hall 6.1, booth K16
Fraunhofer IMM will present a microfluidic platform device for the fast detection of the virological infection status, e.g. for various serotypes of influenza and several coronaviruses. Another focus will be on a fully automated instrument for the isolation of single CTCs (circulating tumor cells) from human blood exhibited in augmented reality. Furthermore rigid and flexible multisite microelectrode arrays for neural signal recording and stimulation as well as a silicon based 3D force sensor for tactile sensing will be shown.Fraunhofer IMM is a leading contract research organization that has been providing innovative research and development services for over 30 years. With a clear focus on the energy, chemical and diagnostic sectors, the institute works on practical solutions for industry, research institutions and universities.
The project work of IMM supports strategic research fields such as hydrogen technologies, resource efficiency, climate protection, digital health and bioeconomy. In doing so, the institute is guided by global challenges and the goals of sustainable development.
The topics of clean energy, sustainability and health are at the center of its work.The expertise of the Fraunhofer IMM is based on its core competencies in the areas of materials, technologies, processes and engineering. These enable the efficient implementation of complex projects:
The Fraunhofer IMM consistently pursues the goal of developing sustainable and marketable solutions that not only strengthen the competitiveness of its partners, but also actively contribute to solving societal challenges.